Review
Aug 2026
Targeting CDKs in the RNAPII transcription cycle.
This Review examines how transcriptional or co-transcriptional processes become dysregulated in cancer cells, and how this dysfunction might create targetable vulnerabilities, and summarizes advances in therapeutic strategies targeting transcriptional CDKs.
Robert P. Fisher, Matthias Geyer
· Nature reviews. Drug discove... · 0 citations